BERTINARIA, Massimo

BERTINARIA, Massimo  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 80 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
[3-(1H-Imidazol-4-yl)propyl)guanidines Containing Furoxan Moieties: A New Class of H3-Antagonists Endowed with NO-Donor Properties 2003 BERTINARIA M; DI STILO A; TOSCO P; SORBA G; POLI E; POZZOLI C; CORUZZI G; FRUTTERO R; GASCO A
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 2018 Carolina Pellegrini, Matteo Fornai, Rocchina Colucci, Laura Benvenuti, Vanessa D’Antongiovanni, Gianfranco Natale, Federica Fulceri, Marta Giorgis, Elisabetta Marini, Simone Gastaldi, Massimo Bertinaria, Corrado Blandizzi, Luca Antonioli
A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity 2013 Malvina Hoxha; Valerie Capra; Carola Buccellati; Angelo Sala; Mohammed Abrar Abdul Gaffar Shaikh; Clara Cena; Roberta Fruttero; Alberto Gasco; G. Enrico Rovati; Massimo Bertinaria
A new class of NO-donor H3-Antagonists 2004 P. Tosco; M. Bertinaria; A. Di Stilo; E. Marini; B. Rolando; G. Sorba; R. Fruttero; A. Gasco
A New Gateway for Rheumatoid Arthritis: COXIBs with an Improved Cardiovascular Profile 2014 Hoxha, M.; Capra, V.; Buccellati, C.; Sala, A.; Cena, C.; Fruttero, R.; Bertinaria, M.; Rovati, G.E.
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity 2009 Stefano Guglielmo; Massimo Bertinaria; Barbara Rolando; Marco Crosetti; Roberta Fruttero; Vanessa Yardley; Simon L. Croft; Alberto Gasco
A rapid screening for cytochromes P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives 2013 G.E. Tsotsou; G. Di Nardo; S.J. Sadeghi; R. Fruttero; L. Lazzarato; M. Bertinaria ; G. Gilardi
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria 2011 Massimo Bertinaria; Stefano Guglielmo; Barbara Rolando; Marta Giorgis; Cristina Aragno; Roberta Fruttero; Alberto Gasco; Silvia Parapini; Donatella Taramelli; Yuri C. Martins; Leonardo J.M. Carvalho
Amphiphilic NO-Donor Antioxidants 2007 K. CHEGAEV; L. LAZZARATO; B. ROLANDO; E. MARINI; G.V. LOPEZ; M. BERTINARIA; A. DI STILO; R. FRUTTERO; A. GASCO
Anti-Helicobacter pylori Agents Endowed with H2-antagonist Properties 2001 G. SORBA; M. BERTINARIA; A. DI STILO; A. GASCO; M.M. SCALTRITO; M.I. BRENCIAGLIA; F. DUBINI
Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties 2000 G.CORUZZI; M. ADAMI; G. MORINI; C. POZZOLI; C. CENA; M. BERTINARIA; A. GASCO
Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes-7 2020 Gutschow M.; Eynde J.J.V.; Jampilek J.; Kang C.; Mangoni A.A.; Fossa P.; Karaman R.; Trabocchi A.; Scott P.J.H.; Reynisson J.; Rapposelli S.; Galdier S.; Winum J.-Y.; Brullo C.; Prokai-Tatrai K.; Sharma A.K.; Schapira M.; Azuma Y.-T.; Cerchia L.; Spete M.; Torri G.; Collina S.; Geronikaki A.; Garcia-Sosa A.T.; Helena Vasconcelos M.; Sousa M.E.; Kosalec I.; Tuccinardi T.; Duarte I.F.; Salvador J.A.R.; Bertinaria M.; Pellecchia M.; Amato J.; Rastelli G.; Gomes P.A.C.; Guedes R.C.; Sabatier J.-M.; Estevez-Braun A.; Pagano B.; Mangani S.; Ragno R.; Kokotos G.; Brindisi M.; Gonzalez F.V.; Borges F.; Miloso M.; Rautio J.; Munoz-Torrero D.
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation 2016 Spallotta, F; Cencioni, C; Atlante, S; Garella, D; Cocco, M; Mori, M; Mastrocola, R; Kuenne, C; Guenther, S; Nanni, S; Azzimato, V; Zukunft, S; Kornberger, A; Di Stilo, A; Aragno, M; Martelli, F; Farsetti, A; Fleming, I; Braun, T; Beiras-Fernandez, A; Botta, B; Collino, M; Bertinaria, M; Zeiher, Am; Gaetano, C.
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile 2012 Bertinaria M; Rolando B; Giorgis M; Montanaro G; Marini E; Collino M; Benetti E; Daniele PG; Fruttero R; Gasco A.
Carnosine analogues containing Phenol substructures 2012 Giorgis M.; Bertinaria M.; Rolando B.; Montanaro G.; Fruttero R.; Gasco A.
Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor 2021 Gastaldi S.; Boscaro V.; Gianquinto E.; Sandall C.F.; Giorgis M.; Marini E.; Blua F.; Gallicchio M.; Spyrakis F.; Macdonald J.A.; Bertinaria M.
Composti ibridi per il trattamento della malaria cerebrale 2013 Leonardo Jose de Moura Carvalho; Alberto Gasco; Roberta Fruttero; Massimo Bertinaria
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 2021 BLANDIZZI CORRADO, PELLEGRINI CAROLINA, FORNAI MATTEO, ANTONIOLI LUCA, COLUCCI ROCCHINA, BERTINARIA MASSIMO, MARINI ELISABETTA, BOSCARO VALENTINA, GASTALDI SIMONE, COCCO MATTIA
Design and synthesis of encorafenib-based BRAF-V600E degraders 2022 Federica Blua, Marco Marino, Simone Gastaldi, Federica Maione, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Design and synthesis of N-benzoyl amino acid derivatives as DNA methylation inhibitors 2016 Garella, Davide; Atlante, Sandra; Borretto, Emily; Cocco, Mattia; Giorgis, Marta; Costale, Annalisa; Stevanato, Livio; Miglio, Gianluca; Cencioni, Chiara; Fernández de Gortari, Eli; Medina Franco, José L.; Spallotta, Francesco; Gaetano, Carlo; Bertinaria, Massimo